TYPE 1 DIABETES MELLITUS IN 2011 Heterogeneity of T1DM raises questions for therapy

被引：13
作者：
Pozzilli, Paolo [1 ]
机构：
[1] Univ Campus Biomed, Dept Endocrinol & Diabet, I-00128 Rome, Italy
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2012年 / 8卷 / 02期
关键词：
PLACEBO-CONTROLLED TRIAL; STRESS; ISLETS;
D O I：
10.1038/nrendo.2011.228
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Research in 2011 regarding beta-cell destruction, early immunointervention trials and development of late complications in type 1 diabetes mellitus have highlighted the heterogeneity of this disease. Patient phenotyping should be performed for the implementation of tailored therapies, especially taking into account the age at which the disease is diagnosed.
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [21] Evaluating the Influence of Mood and Stress on Glycemic Variability in People with T1DM Using Glucose Monitoring Sensors and Pools
    Velasco, Jose Manuel
    Botella-Serrano, Marta
    Sanchez-Sanchez, Almudena
    Aramendi, Aranzazu
    Martinez, Remedios
    Maqueda, Esther
    Garnica, Oscar
    Contador, Sergio
    Lanchares, Juan
    Hidalgo, Jose Ignacio
    DIABETOLOGY, 2022, 3 (02): : 268 - 275
  • [22] The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
    Benninger, Richard K. P.
    Dorrell, Craig
    Hodson, David J.
    Rutter, Guy A.
    CURRENT DIABETES REPORTS, 2018, 18 (11)
  • [23] Xenograft of Microencapsulated Sertoli Cells Reverses T1DM in NOD Mice by Inducing Neogenesis of Beta-Cells
    Luca, Giovanni
    Fallarino, Francesca
    Calvitti, Mario
    Mancuso, Francesca
    Nastruzzi, Claudio
    Arato, Iva
    Falabella, Giulia
    Grohmann, Ursula
    Becchetti, Ennio
    Puccetti, Paolo
    Calafiore, Riccardo
    TRANSPLANTATION, 2010, 90 (12) : 1352 - 1357
  • [24] Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
    Arif, Sefina
    Leete, Pia
    Nguyen, Vy
    Marks, Katherine
    Nor, Nurhanani Mohamed
    Estorninho, Megan
    Kronenberg-Versteeg, Deborah
    Bingley, Polly J.
    Todd, John A.
    Guy, Catherine
    Dunger, David B.
    Powrie, Jake
    Willcox, Abby
    Foulis, Alan K.
    Richardson, Sarah J.
    de Rinaldis, Emanuele
    Morgan, Noel G.
    Lorenc, Anna
    Peakman, Mark
    DIABETES, 2014, 63 (11) : 3835 - 3845
  • [25] Immune Therapy and β-Cell Death in Type 1 Diabetes
    Lebastchi, Jasmin
    Deng, Songyan
    Lebastchi, Amir H.
    Beshar, Isabel
    Gitelman, Stephen
    Willi, Steven
    Gottlieb, Peter
    Akirav, Eitan M.
    Bluestone, Jeffrey A.
    Herold, Kevan C.
    DIABETES, 2013, 62 (05) : 1676 - 1680
  • [26] The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children
    Talat, Mohamed A.
    Sherief, Laila Metwaly
    El-Saadany, Hosam Fathy
    Rass, Anwar Ahmed
    Saleh, Rabab M.
    Sakr, Maha Mahmoud Hamed
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2016, 8 (04) : 399 - 404
  • [27] Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model
    Pimentel Villaca, Catharina de Barros
    de Paula, Carolina Cavalcante
    de Oliveira, Caroline Cruz
    Vilas-Boas, Eloisa Aparecida
    dos Santos-Silva, Junia Carolina
    de Oliveira, Sergio Ferreira
    Abdulkader, Fernando
    Ferreira, Sandra Mara
    Ortis, Fernanda
    EXPERIMENTAL PHYSIOLOGY, 2021, 106 (07) : 1482 - 1497
  • [28] Laser capture microdissection tailored to type 1 diabetes mellitus research
    Szulawski, Robert
    Nakazawa, Masato
    McCall, Kelly D.
    James, Calvin B. L.
    Schwartz, Frank L.
    BIOTECHNIQUES, 2016, 60 (06) : 293 - 298
  • [29] Transplantation for type 1 diabetes mellitus. Whole organ or islets?
    Vrochides, D.
    Paraskevas, St
    Papanikolaou, V
    HIPPOKRATIA, 2009, 13 (01) : 6 - 8
  • [30] Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
    Rosenzwajg, Michelle
    Churlaud, Guillaume
    Hartemann, Agnes
    Klatzmann, David
    CURRENT DIABETES REPORTS, 2012, 14 (12) : 553 - U21
12345